These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 7509854

  • 1. Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study.
    Rousseau P, Flamant F, Quintana E, Voute PA, Gentet JC.
    J Clin Oncol; 1994 Mar; 12(3):516-21. PubMed ID: 7509854
    [Abstract] [Full Text] [Related]

  • 2. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.
    Stewart RJ, Martelli H, Oberlin O, Rey A, Bouvet N, Spicer RD, Godzinski J, Stevens MC, International Society of Pediatric Oncology.
    J Clin Oncol; 2003 Mar 01; 21(5):793-8. PubMed ID: 12610176
    [Abstract] [Full Text] [Related]

  • 3. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
    Flamant F, Rodary C, Rey A, Praquin MT, Sommelet D, Quintana E, Theobald S, Brunat-Mentigny M, Otten J, Voûte PA, Habrand JL, Martelli H, Barrett A, Terrier-Lacombe MJ, Oberlin O.
    Eur J Cancer; 1998 Jun 01; 34(7):1050-62. PubMed ID: 9849454
    [Abstract] [Full Text] [Related]

  • 4. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
    Stevens MC, Rey A, Bouvet N, Ellershaw C, Flamant F, Habrand JL, Marsden HB, Martelli H, Sanchez de Toledo J, Spicer RD, Spooner D, Terrier-Lacombe MJ, van Unnik A, Oberlin O.
    J Clin Oncol; 2005 Apr 20; 23(12):2618-28. PubMed ID: 15728225
    [Abstract] [Full Text] [Related]

  • 5. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
    Orbach D, Rey A, Oberlin O, Sanchez de Toledo J, Terrier-Lacombe MJ, van Unnik A, Quintana E, Stevens MC.
    J Clin Oncol; 2005 Jul 01; 23(19):4363-71. PubMed ID: 15994146
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report.
    Suarez A, McDowell H, Niaudet P, Comoy E, Flamant F.
    J Clin Oncol; 1991 Dec 01; 9(12):2177-82. PubMed ID: 1720453
    [Abstract] [Full Text] [Related]

  • 7. Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.
    Oberlin O, Rey A, Sanchez de Toledo J, Martelli H, Jenney ME, Scopinaro M, Bergeron C, Merks JH, Bouvet N, Ellershaw C, Kelsey A, Spooner D, Stevens MC.
    J Clin Oncol; 2012 Jul 10; 30(20):2457-65. PubMed ID: 22665534
    [Abstract] [Full Text] [Related]

  • 8. Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study).
    Otten J, Flamant F, Rodary C, Brunat-Mentigny M, Dutou L, Olive D, Quintana E, Voûte PA.
    Cancer Chemother Pharmacol; 1989 Jul 10; 24 Suppl 1():S30. PubMed ID: 2667788
    [No Abstract] [Full Text] [Related]

  • 9. Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee.
    Réguerre Y, Martelli H, Rey A, Rogers T, Gaze M, Ben Arush MW, Devalck C, Oberlin O, Stevens M, Orbach D.
    Eur J Cancer; 2012 Sep 10; 48(13):2020-7. PubMed ID: 22154650
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis.
    Terwisscha van Scheltinga CE, Spronk P, van Rosmalen J, Wijnen MH, Heij HA, van Baren R, Merks JH, van Noesel MM, Wijnen RM.
    J Pediatr Surg; 2014 Mar 10; 49(3):416-9. PubMed ID: 24650468
    [Abstract] [Full Text] [Related]

  • 11. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
    Wessalowski R, Schneider DT, Mils O, Friemann V, Kyrillopoulou O, Schaper J, Matuschek C, Rothe K, Leuschner I, Willers R, Schönberger S, Göbel U, Calaminus G, MAKEI study group.
    Lancet Oncol; 2013 Aug 10; 14(9):843-52. PubMed ID: 23823158
    [Abstract] [Full Text] [Related]

  • 12. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
    Abd El-Aal HH, Habib EE, Mishrif MM.
    J Egypt Natl Canc Inst; 2006 Mar 10; 18(1):51-60. PubMed ID: 17237856
    [Abstract] [Full Text] [Related]

  • 13. Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.
    Winter S, Fasola S, Brisse H, Mosseri V, Orbach D.
    Pediatr Blood Cancer; 2015 Nov 10; 62(11):1935-41. PubMed ID: 26150380
    [Abstract] [Full Text] [Related]

  • 14. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL, Anderson J, Pappo AS, Meyer WH, Children's Oncology Group.
    J Clin Oncol; 2006 Aug 20; 24(24):3844-51. PubMed ID: 16921036
    [Abstract] [Full Text] [Related]

  • 15. Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95.
    Jenney M, Oberlin O, Audry G, Stevens MC, Rey A, Merks JH, Kelsey A, Gallego S, Haie-Meder C, Martelli H.
    Pediatr Blood Cancer; 2014 Feb 20; 61(2):217-22. PubMed ID: 23997024
    [Abstract] [Full Text] [Related]

  • 16. Nonparameningeal head and neck rhabdomyosarcoma in children and adolescents: Lessons from the consecutive International Society of Pediatric Oncology Malignant Mesenchymal Tumor studies.
    Orbach D, Mosseri V, Gallego S, Kelsey A, Devalck C, Brenann B, van Noesel MM, Bergeron C, Merks JH, Rechnitzer C, Jenney M, Minard-Colin V, Stevens M.
    Head Neck; 2017 Jan 20; 39(1):24-31. PubMed ID: 27459057
    [Abstract] [Full Text] [Related]

  • 17. [Prognostic factors in rhabdomyosarcomas in childhood. Study carried out with 253 children registered by the International Society of Pediatric Oncology].
    Rodary C, Rey A, Rezvani A, Flamant F.
    Bull Cancer; 1988 Jan 20; 75(2):213-23. PubMed ID: 3359065
    [Abstract] [Full Text] [Related]

  • 18. High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma.
    Carli M, Colombatti R, Oberlin O, Stevens M, Masiero L, Frascella E, Koscielniak E, Treuner J, Pinkerton CR.
    J Clin Oncol; 1999 Sep 20; 17(9):2796-803. PubMed ID: 10561355
    [Abstract] [Full Text] [Related]

  • 19. Outcomes in paediatric metastatic rhabdomyosarcoma: results of The International Society of Paediatric Oncology (SIOP) study MMT-98.
    McDowell HP, Foot AB, Ellershaw C, Machin D, Giraud C, Bergeron C.
    Eur J Cancer; 2010 Jun 20; 46(9):1588-95. PubMed ID: 20338746
    [Abstract] [Full Text] [Related]

  • 20. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
    Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS.
    J Clin Oncol; 2001 Jun 15; 19(12):3091-102. PubMed ID: 11408506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.